LONDON, May 2, 2019 /PRNewswire/ -- Hikma
Pharmaceuticals PLC (Hikma) (LSE: HIK) (NASDAQ Dubai: HIK)
(OTC: HKMPY), the multinational generic pharmaceutical company,
today announced that it will serve as a Gold Sponsor of the
Massachusetts Institute of Technology's
Grand Hack taking place this weekend (May
3-5, 2019) in Cambridge,
Massachusetts.
The Grand Hack is MIT Hacking Medicine's annual flagship event
dedicated to energise, infect and teach healthcare entrepreneurship
and digital strategies to scale medicine as a way to solve health
problems worldwide. More than 500 participants, mentors and
sponsors from 25 US states and 29 countries are expected to gather
on campus in the MIT Media Lab for this year's Grand Hack, the
largest healthcare hackathon in the US.
As a strategic sponsor, Hikma and its venture capital arm Hikma
Ventures will support the Grand Hack's 'Personalised Medicine'
theme, which focuses on solving challenges in improving
preventative medicine, treatment affordability and personalised
medicine dosages. Hikma will also have representatives
on-site to speak with those attendees interested in exploring
opportunities to join Hikma in its mission of putting better health
within reach of millions of people through its high-quality
medicines and healthcare solutions.
"As a company dedicated to using insight and expertise to
transform cutting-edge science into healthcare solutions that
improve people's lives, Hikma is thrilled to support the MIT Grand
Hack," said Hamzeh Abdul-Hadi,
Senior Associate of Hikma Ventures. "This is an excellent
opportunity to engage with like-minded innovators across the
healthcare spectrum who all share the same enthusiasm and
dedication to helping solve today's healthcare challenges."
"We established Hikma Ventures because we believe that
technology and digital tools in healthcare are now a necessity for
all healthcare stakeholders, and pharma's role will be key in the
adoption and spread of emerging technologies," said Lana Ghanem, Managing Director Hikma Ventures.
Hikma Ventures is the corporate venture capital fund of Hikma that
is focused on investing in global digital health startups. "We
invest in companies that can supplement Hikma's business model and
differentiate Hikma's offering to address a range of healthcare
challenges."
"Hackathon" is a combination of the words "hack" and "marathon."
Hackathons are commonly associated with programming and computer
science but, in health hackathons, not all participants are coders.
They come from diverse backgrounds, address pain points in
healthcare delivery, and assess business viability as an integral
component of their hacks. MIT's
hackathons bring together the whole healthcare ecosystem –
patients, nurses, doctors, engineers, developers, designers,
business people, insurance and policy experts. Together they attack
healthcare challenges using a diverse and interdisciplinary
approach.
MIT Hacking Medicine was founded in 2011 and offers immense
promise to the healthcare community. It comprises
MIT students and community members who
are aimed at energising the healthcare community and accelerating
medical innovation. They accomplish this by carrying out health
hackathons, design thinking workshops, and networking gatherings to
teach healthcare entrepreneurship. The group has organised more
than 150 events across 15 countries and 5 continents. More than 40
companies have been created through these MIT-related hackathons, raising over $150 million in venture funding.
About Hikma
Hikma helps put better health within reach every day for
millions of people in more than 50 countries around the
world. For more than 40 years, we've been creating
high-quality medicines and making them accessible to the people who
need them. Headquartered in the UK, we're a global company
with a local presence across the United
States (US), the Middle
East and North Africa
(MENA) and Europe, and we use our
unique insight and expertise to transform cutting-edge science into
innovative solutions that transform people's lives. We're
committed to our customers, and the people they care for, and by
thinking creatively and acting practically, we provide them with a
broad range of branded and non-branded generic medicines.
Together, our 8,400 colleagues are helping to shape a healthier
world that enriches all our communities. We are a leading
licensing partner in the MENA region, and through our venture
capital arm, are helping bring innovative health technologies to
people around the world. For more information, please visit
www.hikma.com.
About Hikma Ventures
Founded in August 2015,
Hikma Ventures operates as the corporate venture capital arm
of Hikma. Hikma Ventures invests in global start-ups where Hikma's
expertise can accelerate revenue growth and enhance value creation
by providing ventures with access to the resources of a
multinational pharmaceutical company. For more information, please
visit: www.hikmaventures.com.
About MIT Hacking Medicine
MIT Hacking Medicine is an entirely student and volunteer driven
effort, whose mission is to energize and connect the best minds
across the health ecosystem to solve healthcare's biggest
challenges. We foster healthcare entrepreneurship through a unique
approach using health hackathons and design thinking workshops. The
approach entails identifying a problem, breaking it down into its
root components, structuring a solution around a single component,
and building and iterating on the solution. MIT Hacking Medicine
pioneered the healthcare hackathon model in 2011 and has run over
200 events across the US and in over 30 countries worldwide. For
more information, please visit:
hackingmedicine.mit.edu
View original
content:http://www.prnewswire.com/news-releases/hikma-sponsors-mit-grand-hack-to-support-global-healthcare-innovation-300843249.html
SOURCE Hikma